{"entity":{"type":"insider","cik":"0001329154","url":"/insider/0001329154","json_url":"/insider/0001329154.json","name":"Rosenblum Mark J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2005-11-23","last":"2025-11-20","span_basis":"filed_date"},"name_variants":[{"name":"Rosenblum Mark J","source":"filing","n_filings":8,"first_seen":"2005-11-23","last_seen":"2025-11-20"}],"transactions":[{"id":4046411,"accession":"0001615219-25-000177","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615219-25-000177","line_url":"/filing/0001615219-25-000177#line-1","is_derivative":false,"issuer_cik":"0001329154","issuer_name":"Salarius Pharmaceuticals, Inc.","issuer_ticker":"SLRX","issuer_name_source":null,"issuer_url":"/issuer/0001329154","owner_cik":"0001329154","owner_name":"Rosenblum Mark J","owner_display_name":"Rosenblum Mark J","owner_url":"/insider/0001329154","role":"Officer (Exec VP Finance, CFO)","role_mark":"O","role_mark_label":"Officer (Exec VP Finance, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP Finance, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":16000.0,"total_display":"16,000.00","total_whole":"16,000","shares_owned_after":20177.0,"shares_owned_after_display":"20,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-20","scope":"insider"},{"id":6134829,"accession":"0001615219-22-000085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615219-22-000085","line_url":"/filing/0001615219-22-000085#line-1","is_derivative":false,"issuer_cik":"0001329154","issuer_name":"Salarius Pharmaceuticals, Inc.","issuer_ticker":"SLRX","issuer_name_source":null,"issuer_url":"/issuer/0001329154","owner_cik":"0001329154","owner_name":"Rosenblum Mark J","owner_display_name":"Rosenblum Mark J","owner_url":"/insider/0001329154","role":"Officer (Exec VP Finance, CFO)","role_mark":"O","role_mark_label":"Officer (Exec VP Finance, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP Finance, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28000.0,"shares_display":"28,000","price_per_share":0.18,"price_display":"0.18","price_state":"stated","total_value":5040.0,"total_display":"5,040.00","total_whole":"5,040","shares_owned_after":148319.0,"shares_owned_after_display":"148,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-31","filed_date":"2022-05-31","scope":"insider"},{"id":6732706,"accession":"0001615219-22-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615219-22-000019","line_url":"/filing/0001615219-22-000019#line-1","is_derivative":false,"issuer_cik":"0001329154","issuer_name":"Salarius Pharmaceuticals, Inc.","issuer_ticker":"SLRX","issuer_name_source":null,"issuer_url":"/issuer/0001329154","owner_cik":"0001329154","owner_name":"Rosenblum Mark J","owner_display_name":"Rosenblum Mark J","owner_url":"/insider/0001329154","role":"Officer (Exec VP Finance, CFO)","role_mark":"O","role_mark_label":"Officer (Exec VP Finance, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP Finance, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76246.0,"shares_display":"76,246","price_per_share":0.391,"price_display":"0.39","price_state":"stated","total_value":29812.186,"total_display":"29,812.19","total_whole":"29,812","shares_owned_after":110319.0,"shares_owned_after_display":"110,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-09","scope":"insider"},{"id":2653103,"accession":"0001615219-20-000092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615219-20-000092","line_url":"/filing/0001615219-20-000092#line-1","is_derivative":false,"issuer_cik":"0001329154","issuer_name":"Salarius Pharmaceuticals, Inc.","issuer_ticker":"SLRX","issuer_name_source":null,"issuer_url":"/issuer/0001329154","owner_cik":"0001329154","owner_name":"Rosenblum Mark J","owner_display_name":"Rosenblum Mark J","owner_url":"/insider/0001329154","role":"Officer (Exec VP Finance, CFO)","role_mark":"O","role_mark_label":"Officer (Exec VP Finance, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP Finance, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-18","scope":"insider"},{"id":2653098,"accession":"0001615219-20-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615219-20-000005","line_url":"/filing/0001615219-20-000005#line-1","is_derivative":false,"issuer_cik":"0001329154","issuer_name":"Salarius Pharmaceuticals, Inc.","issuer_ticker":"SLRX","issuer_name_source":null,"issuer_url":"/issuer/0001329154","owner_cik":"0001329154","owner_name":"Rosenblum Mark J","owner_display_name":"Rosenblum Mark J","owner_url":"/insider/0001329154","role":"Officer (Exec VP Finance, CFO)","role_mark":"O","role_mark_label":"Officer (Exec VP Finance, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP Finance, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":1900.0,"total_display":"1,900.00","total_whole":"1,900","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-19","filed_date":"2020-02-20","scope":"insider"},{"id":2716832,"accession":"0001615219-20-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615219-20-000001","line_url":"/filing/0001615219-20-000001#line-1","is_derivative":false,"issuer_cik":"0001329154","issuer_name":"Salarius Pharmaceuticals, Inc.","issuer_ticker":"SLRX","issuer_name_source":null,"issuer_url":"/issuer/0001329154","owner_cik":"0001329154","owner_name":"Rosenblum Mark J","owner_display_name":"Rosenblum Mark J","owner_url":"/insider/0001329154","role":"Officer (Exec VP Finance, CFO)","role_mark":"O","role_mark_label":"Officer (Exec VP Finance, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP Finance, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.859,"price_display":"0.86","price_state":"stated","total_value":4295.0,"total_display":"4,295.00","total_whole":"4,295","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-13","scope":"insider"},{"id":5288395,"accession":"0001144204-13-057268","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-057268","line_url":"/filing/0001144204-13-057268#line-1","is_derivative":false,"issuer_cik":"0001100397","issuer_name":"Advaxis, Inc.","issuer_ticker":"ADXS","issuer_name_source":null,"issuer_url":"/issuer/0001100397","owner_cik":"0001329154","owner_name":"Rosenblum Mark J","owner_display_name":"Rosenblum Mark J","owner_url":"/insider/0001329154","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":48000.0,"total_display":"48,000.00","total_whole":"48,000","shares_owned_after":20196.0,"shares_owned_after_display":"20,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-24","filed_date":"2013-10-28","scope":"insider"},{"id":1236847,"accession":"0000911420-05-000504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911420-05-000504","line_url":"/filing/0000911420-05-000504#line-1","is_derivative":false,"issuer_cik":"0001301348","issuer_name":"HEMOBIOTECH INC","issuer_ticker":"HMBT","issuer_name_source":null,"issuer_url":"/issuer/0001301348","owner_cik":"0001329154","owner_name":"Rosenblum Mark J","owner_display_name":"Rosenblum Mark J","owner_url":"/insider/0001329154","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","total_whole":"3,000","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-21","filed_date":"2005-11-23","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001615219","name":"Salarius Pharmaceuticals, Inc.","url":"/issuer/0001615219","role":"Officer (Exec VP Finance, CFO)","n_filings":6,"first_seen":"2020-02-13","last_seen":"2025-11-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001100397","name":"Advaxis, Inc.","url":"/issuer/0001100397","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2013-10-28","last_seen":"2013-10-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001301348","name":"HEMOBIOTECH INC","url":"/issuer/0001301348","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2005-11-23","last_seen":"2005-11-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001329154","retrieved_at":"2026-08-22T04:47:42+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}